CN Patent
CN114213399B — 一种卡格列净丙酮水合物及其制备方法和用途
Assigned to Shanghai Qixun Pharmaceutical Technology Co ltd · Expires 2024-10-01 · 2y expired
What this patent protects
本发明公开了一种如式I所示的卡格列净丙酮水合物: 其中,0.6≤x≤1.2,0.5≤y≤1.0。
USPTO Abstract
本发明公开了一种如式I所示的卡格列净丙酮水合物: 其中,0.6≤x≤1.2,0.5≤y≤1.0。
Drugs covered by this patent
- Farxiga (DAPAGLIFLOZIN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.